Cargando…

Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma

BACKGROUND: We previously showed that the expression of follistatin-like protein 1 (FSTL1) was significantly down-regulated in metastatic clear-cell renal cell carcinoma (ccRCC). In this study, we aimed to characterize the role of FSTL1 in the development of ccRCC. METHODS: The effects of FSTL1 on c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Tan, Xiaojie, Liu, Wenbin, Chen, Xi, Hou, Xiaomei, Shen, Dan, Ding, Yibo, Yin, Jianhua, Wang, Ling, Zhang, Hongwei, Yu, Yongwei, Hou, Jianguo, Thompson, Timothy C., Cao, Guangwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778637/ https://www.ncbi.nlm.nih.gov/pubmed/29357946 http://dx.doi.org/10.1186/s40880-018-0267-2

Ejemplares similares

A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression
por: Liu, Yan, et al.
Publicado: (2016)

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients
por: Tan, Xiaojie, et al.
Publicado: (2013)

Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus
por: Tan, Xiaojie, et al.
Publicado: (2015)

A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma
por: SU, TONG, et al.
Publicado: (2013)

KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
por: Zheng, Jing-min, et al.
Publicado: (2021)

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma
por: Pu, Rui, et al.
Publicado: (2022)

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
por: Seachrist, Darcie D., et al.
Publicado: (2017)

TRPV1 acts as a Tumor Suppressor and is associated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma: evidence from integrated analysis
por: Zheng, Long, et al.
Publicado: (2020)

Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
por: Fan, Nengguang, et al.
Publicado: (2013)

Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study
por: Jiang, Dongming, et al.
Publicado: (2021)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021)

Follistatin and the Breast Implant Capsule
por: Frenkiel, Brett A., et al.
Publicado: (2017)

Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
por: Hou, Lin, et al.
Publicado: (2023)

Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Zhao, Enyang, et al.
Publicado: (2022)

Follistatin Protein Enhances Satellite Cell Counts in Reinnervated Muscle
por: Feger, Mark A., et al.
Publicado: (2022)

Cancer mortality trends in an industrial district of Shanghai, China, from 1974 to 2014, and projections to 2029
por: Li, Mi, et al.
Publicado: (2017)

The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Circular RNA ITCH Is a Tumor Suppressor in Clear Cell Renal Cell Carcinoma Metastasis through miR-106b-5p/PDCD4 Axis
por: Gao, Ping, et al.
Publicado: (2021)

Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans
por: Chen, Fangfang, et al.
Publicado: (2014)

Inactivating hepatic follistatin alleviates hyperglycemia
por: Tao, Rongya, et al.
Publicado: (2018)

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma
por: Li, Ting, et al.
Publicado: (2015)

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
por: Schelleckes, Katrin, et al.
Publicado: (2017)

RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
por: Chen, Weihao, et al.
Publicado: (2016)

RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma
por: ZHU, DAWEI, et al.
Publicado: (2022)

Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma
por: Krasnov, George S., et al.
Publicado: (2023)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

Hypermethylation of BRM promoter plays oncogenic roles in development of clear cell renal cell carcinoma
por: Fang, Ru, et al.
Publicado: (2019)

Somatic Mutations, Viral Integration and Epigenetic Modification in the Evolution of Hepatitis B Virus-Induced Hepatocellular Carcinoma
por: Ji, Xiaowei, et al.
Publicado: (2014)

TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma
por: Li, Qiang, et al.
Publicado: (2023)

Follistatin is a crucial chemoattractant for mouse decidualized endometrial stromal cell migration by JNK signalling
por: Liu, Guole, et al.
Publicado: (2022)

Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
por: Hou, Weibin, et al.
Publicado: (2018)

Serum Activin A and Follistatin Levels in Gestational Diabetes and the Association of the Activin A-Follistatin System with Anthropometric Parameters in Offspring
por: Näf, Silvia, et al.
Publicado: (2014)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
por: Sun, Xiaomei, et al.
Publicado: (2023)

SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas
por: Dufies, Maeva
Publicado: (2020)

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
por: Liu, Jiluo, et al.
Publicado: (2021)

Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome
por: Kim, Ji-Hee, et al.
Publicado: (2016)

Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma
por: Huang, Shiyu, et al.
Publicado: (2022)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dcajqhbfae6j7drauldktalcm4